These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38489516)

  • 41. The value of liver stiffness measured by two-dimensional shear wave elastography for predicting symptomatic posthepatectomy liver failure in patients with hepatocellular carcinoma.
    Shi Y; Long H; Zhong X; Peng J; Su L; Duan Y; Ke W; Xie X; Lin M
    Eur J Radiol; 2022 May; 150():110248. PubMed ID: 35299113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.
    Reiberger T; Ferlitsch A; Payer BA; Pinter M; Schwabl P; Stift J; Trauner M; Peck-Radosavljevic M
    Wien Klin Wochenschr; 2012 Jun; 124(11-12):395-402. PubMed ID: 22699260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
    Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
    J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Dajti E; Ravaioli F; Marasco G; Alemanni LV; Colecchia L; Ferrarese A; Cusumano C; Gemini S; Vestito A; Renzulli M; Golfieri R; Festi D; Colecchia A
    Am J Gastroenterol; 2022 Nov; 117(11):1825-1833. PubMed ID: 35973171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
    Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
    World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noninvasive assessment of liver fibrosis and portal hypertension.
    Duarte-Rojo A; Patel K; Rockey DC
    Curr Opin Gastroenterol; 2024 May; 40(3):148-155. PubMed ID: 38547334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis.
    Thiele M; Hugger MB; Kim Y; Rautou PE; Elkrief L; Jansen C; Verlinden W; Allegretti G; Israelsen M; Stefanescu H; Piscaglia F; García-Pagán JC; Franque S; Berzigotti A; Castera L; Jeong WK; Trebicka J; Krag A
    Liver Int; 2020 Jun; 40(6):1435-1446. PubMed ID: 32180327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China.
    Liu C; Zhang L; Zhang S; Li X; Wong YJ; Liang X; Wang Y; Wu X; Gou W; Lv J; Hu S; Fu J; Huang J; Ge G; Huang M; Wang F; Zhang Q; Ren T; Meng Z; Ding D; Zhuoga B; Zhuoga C; Fan J; Dang D; Miao L; Song Z; Xiao X; Wu H; Jiang K; Liu T; Gao Y; Ma L; Fang T; Wang Y; Zhang Q; Zhu D; Ji D; Cao Z; Zeng QL; Li J; Chen P; Wei Y; Tong Z; Hong Z; Liang X; Li Y; Nan Y; Qi X
    BMJ Open; 2024 Jul; 14(7):e081623. PubMed ID: 38991669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
    Wang C; Huang Y; Liu C; Liu F; Hu X; Kuang X; An W; Liu C; Liu Y; Liu S; He R; Wang H; Qi X
    Radiology; 2023 Apr; 307(2):e221648. PubMed ID: 36719293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests?
    Dajti E; Alemanni LV; Marasco G; Montagnani M; Azzaroli F
    Hepat Med; 2021; 13():25-36. PubMed ID: 33776492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging.
    Palaniyappan N; Cox E; Bradley C; Scott R; Austin A; O'Neill R; Ramjas G; Travis S; White H; Singh R; Thurley P; Guha IN; Francis S; Aithal GP
    J Hepatol; 2016 Dec; 65(6):1131-1139. PubMed ID: 27475617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
    Jiang FR; Yan HD
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395
    [No Abstract]   [Full Text] [Related]  

  • 53. Spleen Stiffness Measurement Across the Spectrum of Liver Disease Patients in Real-World Practice.
    Lantinga MA; van Kleef LA; den Hoed CM; De Knegt RJ
    J Clin Exp Hepatol; 2023; 13(3):414-427. PubMed ID: 37250876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
    Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2020 Jul; 40(7):1713-1724. PubMed ID: 32358998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnostic accuracy of liver and spleen stiffness by two dimensional shear wave elastography for portal hypertension in hepatitis B-related cirrhosis].
    Zhu YL; Ding H; Fu TT; Xu ZT; Xue LY; Chen SY; Wang WP
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1654-1657. PubMed ID: 32486601
    [No Abstract]   [Full Text] [Related]  

  • 56. Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.
    Elkrief L; Lazareth M; Chevret S; Paradis V; Magaz M; Blaise L; Rubbia-Brandt L; Moga L; Durand F; Payancé A; Plessier A; Chaffaut C; Valla D; Malphettes M; Diaz A; Nault JC; Nahon P; Audureau E; Ratziu V; Castera L; Garcia Pagan JC; Ganne-Carrie N; Rautou PE;
    Hepatology; 2021 Jul; 74(1):364-378. PubMed ID: 33345307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancing liver cirrhosis varices and CSPH risk prediction with spleen stiffness measurement using 100-Hz probe.
    Yoo JJ; Maeng SA; Chang Y; Lee SH; Jeong SW; Jang JY; Cheon GJ; Kim YS; Kim HS; Kim SG
    Sci Rep; 2024 Jun; 14(1):13674. PubMed ID: 38871788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.
    Schwabl P; Bota S; Salzl P; Mandorfer M; Payer BA; Ferlitsch A; Stift J; Wrba F; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Feb; 35(2):381-90. PubMed ID: 24953516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography.
    Zocco MA; Cintoni M; Ainora ME; Garcovich M; Lupascu A; Iezzi R; Annichiarico BE; Siciliano M; Riccardi L; Rapaccini GL; Grieco A; Pompili M; Gasbarrini A
    Ultraschall Med; 2023 Aug; 44(4):428-435. PubMed ID: 36526267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression.
    Jachs M; Hartl L; Bauer D; Simbrunner B; Stättermayer AF; Strassl R; Trauner M; Mandorfer M; Reiberger T
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.